Relaxin decreases renal interstitial fibrosis and slows progression of renal disease-Reference-Cited by-同舟云学术

Relaxin decreases renal interstitial fibrosis and slows progression of renal disease

Published:2001-03 Issue:3 Volume:59 Page:876-882
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Garber Sandra L.,Mirochnik Yelena,Brecklin Carolyn S.,Unemori Elaine N.,Singh Ashok K.,Slobodskoy Leonid,Grove Beverly H.,Arruda Jose A.L.,Dunea George

Publisher

Elsevier BV

Subject

Nephrology

Reference15 articles.

1. Angiotensin-converting enzyme inhibition reduces the effect of Bromoethylamine-induced papillary necrosis and renal fibrosis;Garber;J Am Soc Nephrol,1998

2. Changes in collagenases and TGF-β precede structural alterations in a model of chronic renal fibrosis;Mo;Kidney Int,1999

3. Evolution of experimentally induced papillary necrosis to focal segmental glomerular sclerosis and nephrotic proteinuria;Garber;Am J Kidney Dis,1999

4. Relaxin modulates synthesis and secretion of procollagenase and collagen in human dermal fibroblasts;Unemori;J Biol Chem,1990

5. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo;Unemori;J Clin Invest,1996

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering and Characterization of a Long-Half-Life Relaxin Receptor RXFP1 Agonist;Molecular Pharmaceutics;2024-08-12

2. Review the Diverse Influences of Relaxin-Like Peptide Family on Tumor Progression: Potential Opportunities and Emerging Challenges;2023

3. Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease;International Journal of Molecular Sciences;2022-05-27

4. Engineering and characterization of a long half-life relaxin receptor RXFP1 agonist;2022-04-19

5. Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/β-catenin signaling pathway;Renal Failure;2022-03-21